Browse studies

Find your next paid study

27,293 recruiting studies available now

A Hybrid Mobile Phone Family Intervention to Prevent Childhood Obesity

Consumption of sweetened beverages, media-viewing, and physical activity patterns are often established during early childhood, and family-based obesity interv…

Childhood Obesity

Documented

$25 – $35/visit

University of California, Los AngelesNCT05606731

Phase 2

A Phase II Study of Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) in Patients With Progressing Metastatic Neuroendocrine Carcinomas (NECs)

This phase IIa trial compares the safety and effect of temozolomide combined with survivin long peptide vaccine (SurVaxM) to temozolomide alone in patients wit…

Digestive System Neuroendocrine NeoplasmLung Neuroendocrine NeoplasmMalignant Solid Neoplasm+1 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Roswell Park Cancer InstituteNCT06202066

Observational

CONNECT-AKI: COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury - A Pilot Randomized Controlled Trial

The goal of this clinical trial is to learn whether different ways of providing information and follow-up support after acute kidney injury, also called AKI, c…

Acute Kidney InjuryAcute Kidney Injury (AKI)

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Northwell HealthNCT07626268

Phase 3

MK-5684-004: A Phase 3, Randomized, Open-label Study of Opevesostat Versus Alternative Abiraterone Acetate or Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) That Progressed On or After Prior Treatment With One Next-generation Hormonal Agent (NHA) (OMAHA-004)

The purpose of this study is to assess the efficacy and safety of opevesostat plus daily corticosteroids compared to alternative abiraterone acetate or enzalut…

Metastatic Castration-resistant Prostate Cancer (mCRPC)Prostatic Neoplasms

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT06136650

Phase 2

Phase II Study of Nirogacestat in Patients With Kaposi Sarcoma

This phase II trial studies how well nirogacestat works in treating patients with skin Kaposi sarcoma (KS). Several anti-cancer drugs work well in treating KS,…

Estimated

~$75 – $3,000

Actual pay is set by the research site.

AIDS Malignancy ConsortiumNCT07539454

Phase 2

Phase 2 Study of Golcadomide With Rituximab as a Bridging Therapy Prior to CAR-T for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)

This phase II trial tests the effectiveness of golcadomide and rituximab as bridging treatment before chimeric antigen receptor (CAR) T-cell therapy in patient…

Large B-Cell Lymphoma With IRF4 RearrangementRecurrent Aggressive B-Cell Non-Hodgkin LymphomaRecurrent ALK-Positive Large B-Cell Lymphoma+28 more

Phase 1

VRC 329: A Phase I Open-Label, Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (STEMos1) With and Without ALFQ Adjuvant in Healthy Adults

Background: Influenza (flu) is a contagious respiratory illness caused by viruses. Flu symptoms can range from mild to severe, and the illness can be fatal. V…

Influenza PreventionPandemic Influenza Prevention

Estimated

~$500 – $6,750

Actual pay is set by the research site.

National Institute of Allergy and Infectious Diseases (NIAID)NCT07111078

Phase 2

A Placebo-controlled, Parallel-group, Double Blind, Randomized, Multi-cohort Phase 2 Study to Investigate Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BAY 3670549 in Adult Participants With Atrial Fibrillation.

The main goal of this study is to find out how well BAY 3670549 works, how safe it is, how well people can tolerate it, and how the body handles the medicine. …

Atrial Fibrillation

Estimated

~$75 – $3,000

Actual pay is set by the research site.

BayerNCT07625215

Observational

Cancer Pain 101: A Digital, Asynchronous Intervention of Pain Management in Advanced Cancer

This is a Stage 1 study of a behavioral intervention, which means that a new intervention is being pilot tested to understand whether it is acceptable and feas…

CancerPainAdvanced Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Alabama at BirminghamNCT07852468

Phase 1

Window of Opportunity Study of Lixumistat in Patients With Newly Diagnosed Glioblastoma

The purpose of this study is to determine the effect of Lixumistat in patients with newly diagnosed Glioblastoma.

Glioblastoma

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Macarena De La Fuente, MDNCT07884344

Phase 3

Randomized, Prospective, Double Blind, Multi-Center, Phase 3 Pivotal Clinical Trial to Compare Efficacy and Safety of CARTISTEM® and Surgical Comparator in Subjects With Knee Cartilage Lesions and Osteoarthritis

To establish the efficacy and safety of CARTISTEM®, a combination product composed of allogeneic human umbilical cord blood-derived mesenchymal stem cells (hUC…

Knee Cartilage Defects

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Medipost, Inc.NCT07339111

Phase 1

Transplantation of CRISPRCas9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease

This is an open label, non-randomized, 2-center, phase 1/2 trial of a single infusion of sickle allele modified cluster of differentiation (CD34+) hematopoieti…

Sickle Cell Disease

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Mark Walters, MDNCT04774536